J. Thaler

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Josep Tabernero, Enrico Mini, Fabien Subtil et al. · The Lancet Oncology · 2014 · 279 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +8

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

R Zittoun, Stefan Suciu, Maggie Watson et al. · Bone Marrow Transplantation · 1997 · 130 citations

Hematological Malignancy, Quality Of Life, Transplantation +10

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

R Zittoun, Stefan Suciu, Franco Mandelli et al. · Journal of Clinical Oncology · 1996 · 122 citations

Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer

Anthony D. Ho, J. Thaler, P Stryckmans et al. · JNCI Journal of the National Cancer Institute · 1990 · 87 citations

Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group

H. Döhner, Anthony D. Ho, J. Thaler et al. · JNCI Journal of the National Cancer Institute · 1993 · 69 citations